Nisargalaya Drug Unit Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-06-2024
- Paid Up Capital ₹ 5.00 M
as on 30-06-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 30-06-2024
- Revenue 29.33%
(FY 2020)
- Profit 92.83%
(FY 2020)
- Ebitda 78.28%
(FY 2020)
- Net Worth -6.42%
(FY 2020)
- Total Assets -15.30%
(FY 2020)
About Nisargalaya Drug Unit
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹5.00 Cr.
Prabhu Byregowda and Siddesha Moogannagowda serve as directors at the Company.
- CIN/LLPIN
U24234KA2011PTC059037
- Company No.
059037
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nisargalaya Drug Unit Private Limited offer?
Nisargalaya Drug Unit Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Fitness Supplements, Hand Sanitizers & Personal Hygiene, Bath Soaps, Ayurvedic Pain Relief Oil, Muscle Pain Oil, Skin Care Oil, Herbal Cosmetics, Herbal Fairness Cream, Face Cream.
Who are the key members and board of directors at Nisargalaya Drug Unit?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhu Byregowda  | Managing Director | 08-Jun-2011 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siddesha Moogannagowda | Director | 22-Dec-2016 | Current |
Financial Performance of Nisargalaya Drug Unit.
Nisargalaya Drug Unit Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 29.33% increase. The company also saw a substantial improvement in profitability, with a 92.83% increase in profit. The company's net worth dipped by a decrease of 6.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nisargalaya Drug Unit?
In 2020, Nisargalaya Drug Unit had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nisargalaya Herbal Company Private LimitedActive 13 years 18 daysPrabhu Byregowda and Siddesha Moogannagowda are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Jul 2017 | ₹5.00 Cr | Open |
How Many Employees Work at Nisargalaya Drug Unit?
Nisargalaya Drug Unit has a workforce of 16 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nisargalaya Drug Unit, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nisargalaya Drug Unit's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
